chemotherapy

You have access
Efficacy of FOLFOX Chemotherapy in Metastatic Enteropancreatic Neuroendocrine Tumors
SANDRINE OZIEL-TAIEB, CHRISTOPHE ZEMMOUR, JEAN-LUC RAOUL, LAURENT MINEUR, FLORA POIZAT, NATHALIE CHARRIER, GILLES PIANA, GERARD CAVAGLIONE and PATRICIA NICCOLI

Anticancer Research April 2021, 41 (4) 2071-2078; DOI: https://doi.org/10.21873/anticanres.14977
You have access
A Retrospective Analysis of Perioperative Chemotherapy and Coronavirus Disease in Patients With Breast Cancer
KAZUMI HAYASHI, MIHO TAMURA, EIJIRO NAGASAKI, YUKIKO YOSHII, TAKAYUKI ISHIGAKI, TAKASHI KAZAMA, MAKIKO KAMIO, HIROKO NOGI, YASUO TORIUMI, HIROSHI TAKEYAMA and SHINGO YANO

Anticancer Research April 2021, 41 (4) 2193-2195; DOI: https://doi.org/10.21873/anticanres.14994
You have access
Inhibition of Heat-shock Protein 27 Reduces 5-Fluorouracil-acquired Resistance in Human Colon Cancer Cells
YUSUKE ASADA, MASASHI TSURUTA, KOJI OKABAYASHI, KOHEI SHIGETA, TAKASHI ISHIDA, TAKEHIRO SHIMADA, HIROFUMI SUZUMURA, KAORU KOISHIKAWA, SHINGO AKIMOTO, HIROTOSHI HASEGAWA and YUKO KITAGAWA

Anticancer Research March 2021, 41 (3) 1283-1290; DOI: https://doi.org/10.21873/anticanres.14885
You have access
Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26
EGLE ZALYTE, VERONIKA DEDONYTE, BENEDIKTAS KURLINKUS, AUDRIUS SILEIKIS, PETER SCHEMMER and MINDAUGAS VALIUS

Anticancer Research March 2021, 41 (3) 1401-1406; DOI: https://doi.org/10.21873/anticanres.14897
You have access
Efficacy of Adjuvant Chemotherapy According to the Pathological Response to Neoadjuvant Chemotherapy Among Patients With Pancreatic Ductal Adenocarcinoma
SHOZO MORI, TAKU AOKI, YUHKI SAKURAOKA, TAKAYUKI SHIMIZU, TAKAMUNE YAMAGUCHI, KYUNG-HWA PARK, TAKATSUGU MATSUMOTO, TAKAYUKI SHIRAKI, YUKIHIRO ISO and KEIICHI KUBOTA

Anticancer Research March 2021, 41 (3) 1629-1639; DOI: https://doi.org/10.21873/anticanres.14925
You have access
Salvage Therapy After Regorafenib or Trifluridine/Tipiracil Treatment of Metastatic Colorectal Cancer: A Conditional Landmark Analysis
MASAYUKI NAKASHIMA, MASATO TAKEUCHI, SHIRO TANAKA and KOJI KAWAKAMI

Anticancer Research February 2021, 41 (2) 1055-1062; DOI: https://doi.org/10.21873/anticanres.14862
You have access
Chemoradiotherapy in Cancer Treatment: Rationale and Clinical Applications
KATHRINE S. RALLIS, THOMAS HO LAI YAU and MICHAIL SIDERIS

Anticancer Research January 2021, 41 (1) 1-7; DOI: https://doi.org/10.21873/anticanres.14746
You have access
Distribution and Expression of the Adhesion Molecule CD44 on Human Corneal Grafts Is Not Altered by Chemotherapy
GEORGIOS S. DIMTSAS, XANTHIPPI GRAMMATOGLOU, THEODOSIA CHOREFTAKI, MARIA DETTORAKI, AIKATERI KARATHANOU, NIKOLAOS GOULIOPOULOS, CHRISTOS DAMASKOS and MARILITA M. MOSCHOS

Anticancer Research December 2020, 40 (12) 6885-6889; DOI: https://doi.org/10.21873/anticanres.14711
You have access
Efficacy of Gemcitabine-based Chemotherapy in Clear Cell Sarcoma of Soft Tissue
ELENA COJOCARU, KHIN THWAY, CYRIL FISHER, CHRISTINA MESSIOU, SHANE ZAIDI, AISHA B. MIAH, CHARLOTTE BENSON, SPYRIDON GENNATAS, PAUL HUANG and ROBIN L. JONES

Anticancer Research December 2020, 40 (12) 7003-7007; DOI: https://doi.org/10.21873/anticanres.14725
You have access
Small Cell Lung Carcinoma and Synchronous Rectal Adenocarcinoma and Jejunal Gastrointestinal Stromal Tumor Present in a Patient With History of Laryngeal Squamous Cell Carcinoma
BOWEI LIU, SHARON SHIRAGA, MELINDA M. MORTENSON and JINPING LAI

Anticancer Research December 2020, 40 (12) 7053-7056; DOI: https://doi.org/10.21873/anticanres.14732

Main menu

User menu

Search

chemotherapy

Pages